ES8802154A1 - Procedimiento para la produccion de tiazoles., - Google Patents

Procedimiento para la produccion de tiazoles.,

Info

Publication number
ES8802154A1
ES8802154A1 ES556363A ES556363A ES8802154A1 ES 8802154 A1 ES8802154 A1 ES 8802154A1 ES 556363 A ES556363 A ES 556363A ES 556363 A ES556363 A ES 556363A ES 8802154 A1 ES8802154 A1 ES 8802154A1
Authority
ES
Spain
Prior art keywords
psychogeriatric
anxioltic
antisepressant
antischiziphrenic
piperazines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES556363A
Other languages
English (en)
Other versions
ES556363A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8802154A1 publication Critical patent/ES8802154A1/es
Publication of ES556363A0 publication Critical patent/ES556363A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

LOS TIADIZOLES (I), DONDE NO EXCLUSIVAMENTE R1 Y R2 SON ALQUILO C1-6 O FENILO, X-Y-N-CH2, CFCH, W ALQUILENO C2-6 Y R3, UN GRUPO TIPO (II) O (III); SE OBTIENEN ENTRE OTROS, POR REACCION DE UN COMPUESTO (IV) CON OTRO Q-W-R''3, CON Q UN GRUPO ELIMINABLE COMO HALOGENO O -O-SO2-R13, EN DISOLVENTE COMO LA DIMETILFORMAMIDA, EN PRESENCIA DE UN AGENTE LIGADOR DE ACIDO, COMO EL CARBONATO DE POTASIO, EN ATMOSFERA DE ARGON Y ENTRE C60 Y C50JC. TIENEN UNA ACTIVIDAD MEJORADORA DE LA INTERACCION SOCIAL Y REDUCTORA DEL CONFLICTO Y AFINIDAD POR LOS LUGARES DE LIGACION 5HT-1A, POR LO QUE SON APLICABLES , COMO ANXIOLITICOS, PSICOGERIATRICOS, ANTIDEPRESIVOS Y ANTIESQUIZOFRENICOS.
ES556363A 1985-06-22 1986-06-20 Procedimiento para la produccion de tiazoles., Expired ES8802154A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3522351 1985-06-22
DE3522353 1985-06-22
DE3522354 1985-06-22
DE3605868 1986-02-24

Publications (2)

Publication Number Publication Date
ES8802154A1 true ES8802154A1 (es) 1988-04-01
ES556363A0 ES556363A0 (es) 1988-04-01

Family

ID=27433378

Family Applications (2)

Application Number Title Priority Date Filing Date
ES556363A Expired ES8802154A1 (es) 1985-06-22 1986-06-20 Procedimiento para la produccion de tiazoles.,
ES557723A Expired ES8802045A1 (es) 1985-06-22 1987-09-15 Procedimiento para la produccion de tiazoles

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557723A Expired ES8802045A1 (es) 1985-06-22 1987-09-15 Procedimiento para la produccion de tiazoles

Country Status (17)

Country Link
US (2) US4737500A (es)
AU (1) AU5894086A (es)
BE (1) BE904945A (es)
CH (1) CH668426A5 (es)
DK (1) DK292986A (es)
ES (2) ES8802154A1 (es)
FI (1) FI862644A7 (es)
FR (1) FR2587342A1 (es)
GB (1) GB2177395B (es)
GR (1) GR861601B (es)
HU (1) HUT43600A (es)
IL (1) IL79178A0 (es)
IT (1) IT1203806B (es)
LU (1) LU86487A1 (es)
NL (1) NL8601494A (es)
PH (1) PH23389A (es)
SE (1) SE8602723L (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
HUT43600A (en) * 1985-06-22 1987-11-30 Sandoz Ag Process for production of new thiazole derivatives and medical compound containing those
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
FR2612187B1 (fr) * 1987-03-12 1989-07-21 Sanofi Sa Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
US4804751A (en) * 1987-06-30 1989-02-14 American Home Products Corporation Polycyclic hydrocarbon succinimides with psychotropic activity
ES2053748T3 (es) * 1987-09-10 1994-08-01 Merck Sharp & Dohme Oxazoles y tiazoles para el tratamiento de la demencia senil.
US4883795A (en) * 1988-01-22 1989-11-28 Pfizer Inc. Piperazinyl-heterocyclic compounds
EP0350145A3 (en) * 1988-04-28 1990-07-04 Yamanouchi Pharmaceutical Co. Ltd. Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both
US4935424A (en) * 1988-05-27 1990-06-19 Warner-Lambert Company 4 or 5-(substituted piperazinylalkyl)-2-aminothiazoles as antipsychotic agents
US5015740A (en) * 1988-08-05 1991-05-14 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
US5077295A (en) * 1988-09-16 1991-12-31 Pfizer Inc. Antipsychoic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)buytl bridged bicycle imides
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
US5130315A (en) * 1991-01-10 1992-07-14 Raymond R. Wittekind 1-piperazinyl-2-butenes and -2-butynes
US5194436A (en) * 1991-01-10 1993-03-16 Hoechst-Roussel Pharmaceuticals Inc. 1-piperazinyl-2-butenes and -2-butynes
IT1251144B (it) * 1991-07-30 1995-05-04 Boehringer Ingelheim Italia Derivati del benzimidazolone
DE69434258T2 (de) * 1993-11-19 2006-01-19 Janssen Pharmaceutica N.V. Mikroverkapselte 1,2-benzazole
US5889010A (en) * 1995-05-18 1999-03-30 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
DE19746612A1 (de) 1997-10-22 1999-04-29 Basf Ag 2-Substituierte 1,2-Benzisothiazol-Derivate, ihre Herstellung und Verwendung
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
RU2445095C2 (ru) * 2004-04-22 2012-03-20 Бёрингер Ингельхайм Интернациональ Гмбх Новые фармацевтические композиции для лечения сексуальных расстройств
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
EP1789048A1 (en) * 2004-09-03 2007-05-30 Boehringer Ingelheim International GmbH Method for the treatment of attention deficit hyperactivity disorder
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
CA2599937A1 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
US20060211685A1 (en) * 2005-03-04 2006-09-21 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of depression
EP1904182A2 (en) * 2005-05-06 2008-04-02 Boehringer Ingelheim International GmbH Method for the treatment of drug abuse with flibanserin
EP1888071A1 (en) * 2005-05-19 2008-02-20 Boehringer Ingelheim International GmbH Method for the treatment of drug-induced sexual dysfunction
EP1912650B8 (en) 2005-08-03 2017-10-18 Sprout Pharmaceuticals, Inc. Use of flibanserin in the treatment of obesity
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
JP2009513604A (ja) 2005-10-29 2009-04-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
DK2021006T3 (en) * 2006-05-09 2015-11-23 Sprout Pharmaceuticals Inc USE OF flibanserin in postmenopausal SEXLYSTFORSTYRRELSER
ATE456369T1 (de) 2006-06-30 2010-02-15 Boehringer Ingelheim Int Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
US20090318469A1 (en) * 2006-07-14 2009-12-24 Boehringer Ingelheim International Gmbh Use of Flibanserin for the Treatment of Sexual Disorders in Females
EA200900264A1 (ru) 2006-08-14 2009-08-28 Бёрингер Ингельхайм Интернациональ Гмбх Композиции флибансерина и способ их приготовления
CL2007002214A1 (es) 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
JP5220746B2 (ja) 2006-08-25 2013-06-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 制御放出システム及びその製造方法
EA017351B1 (ru) * 2007-03-29 2012-11-30 Общество С Ограниченной Ответственностью "Фармвинг" Средство противогистаминного антиаллергического действия и способ его получения
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
CA2686480A1 (en) 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh New salts

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637271A (es) * 1963-04-04 1900-01-01
DE1595923A1 (de) * 1965-02-20 1969-11-27 Merck Ag E 1-Aralkyl-4-(thiazolyl-2)-piperazine und Verfahren zu ihrer Herstellung
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
JPS5246935B1 (es) * 1971-04-06 1977-11-29
BE787059A (fr) * 1971-08-03 1973-02-01 Wander Ag Dr A Nouveaux derives du thiazole, leur preparation et leur application comme medicaments
CH583232A5 (es) * 1973-02-02 1976-12-31 Wander Ag Dr A
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
HUT43600A (en) * 1985-06-22 1987-11-30 Sandoz Ag Process for production of new thiazole derivatives and medical compound containing those

Also Published As

Publication number Publication date
DK292986A (da) 1986-12-23
AU5894086A (en) 1986-12-24
NL8601494A (nl) 1987-01-16
US4737500A (en) 1988-04-12
HUT43600A (en) 1987-11-30
GR861601B (en) 1986-10-20
GB2177395B (en) 1989-04-26
PH23389A (en) 1989-07-26
GB8614974D0 (en) 1986-07-23
FI862644A7 (fi) 1986-12-23
BE904945A (fr) 1986-12-18
IL79178A0 (en) 1986-09-30
FI862644A0 (fi) 1986-06-19
SE8602723L (sv) 1986-12-23
ES556363A0 (es) 1988-04-01
SE8602723D0 (sv) 1986-06-18
ES557723A0 (es) 1988-03-16
CH668426A5 (de) 1988-12-30
ES8802045A1 (es) 1988-03-16
US4892879A (en) 1990-01-09
IT8648157A0 (it) 1986-06-20
DK292986D0 (da) 1986-06-20
IT1203806B (it) 1989-02-23
LU86487A1 (fr) 1987-01-13
FR2587342A1 (fr) 1987-03-20
GB2177395A (en) 1987-01-21

Similar Documents

Publication Publication Date Title
ES8802154A1 (es) Procedimiento para la produccion de tiazoles.,
DE60133405D1 (de) Verfahren zur herstellung von lithiummetallverbindungen, die zur verwendung als kathodenaktivmasse geeignet sind
ATE328057T1 (de) Verwendung von metallkomplexverbindungen als oxidationskatalysatoren
PE20001419A1 (es) COMPLEJO DEL INHIBIDOR DE RAS-FARNESILTRANSFERASA Y SULFOBUTILETER-7-ß-CICLODEXTRINA O 2-HIDROXIPROPIL-ß-CICLODEXTRINA Y METODO
MX9401195A (es) Oligomeros de esteres tapados en los extremos poli-etoxi/propoxisulfonados adecuados como agentes liberadores de sucio en composicionesdetergentes.
ES2066101T3 (es) Catalizadores de oxido de alquileno que tienen una actividad y/o estabilidad mejorada.
AR022803A1 (es) Composiciones blanqueadoras estabilizadas
ES8705026A1 (es) Metodo para estabilizar la razon de descomposicion de peroxiacidos
BR8704798A (pt) Aplicacao de silicatos de camadas,sinteticos,intumesciveis,bem como agentes aquosos de enxaguamento de perfuracoes e tratamento de perfuracoes,e combinacao de substancias ativas
ES2006954A6 (es) Procedimiento de tincion de fibras queratinicas, composicion tintorea y dispositivo de varios compartimentos.
SE9602818D0 (sv) Colored composition
ES2053481T3 (es) Composicion de pigmento.
DK206587D0 (da) Detergentsammensaetning indeholdende overfladeaktive midler, nitrogen-holdigt toejbloedgoeringsmiddel og eventuelt detergensadditiver
IT1098168B (it) Procedimento per l'unione di cuori di scambi ferroviari, cuori che sono costituiti da acciaio fuso duro al manganese,con rotaie costituite da acciaie al carbonio
BR9713160A (pt) Composição utilizável em alvejamento
ES2067628T3 (es) Nuevo compuesto policationico y composicion blanqueante que lo contiene.
EP1553408A4 (en) FLUORESCENCE PROBE
ES8800166A1 (es) Procedimiento para la obtencion de imidazoles sustituidos
ES2128191T3 (es) Composiciones para el teñido por oxidacion de fibras queratinicas y procedimiento de teñido que las utiliza.
ES2081858T3 (es) Compuestos de beta-fenoxinitrilo.
GT198700025A (es) Ciertas 3-amino-2-benzoilciclohex-2-enonas substituidas.
DK0643719T3 (da) Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor
SE8801770D0 (sv) Selektiva borttagningsmedel innehallande peroxid och metod for borttagning
ES2030145T3 (es) Procedimiento para la oxidacion anodica de la superficie de aluminio o aleaciones de aluminio.
IT8921837A0 (it) Composizione di combustibile ad elevato contenuto energetico, contenete quadriciclano.